AMGEN INC
AMGNNASDAQ$418.27▼ $0.13 (−0.03%)
LiveTrack AMGN
Get earnings, price moves & breaking news on Telegram
24h▼ 0.0%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$225.74B
Large Cap
📈Revenue Growth (YoY)
+9.9%
Slowing
📊Gross Margin
72.7%
High
💵FCF Margin
26.7%
Strong
⚖️P/S Ratio
5.9x
Fair
Otter Score
92
Very Good
AMGEN INC
AMGNAnalyst Ratings
Price
$418.27
Total
22
Raised
19
Lowered
2
Avg PT
$402.00
H / L
$500 / $230
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Scotiabank Amgen | Raised | Sector Outperform | 2026-09-29 | $500.00 | +19.50% |
Argus Research Amgen | Raised | Buy | 2026-08-19 | $460.00 | +10.00% |
Piper Sandler Amgen | Raised | Overweight | 2026-08-20 | $457.00 | +9.30% |
TD Cowen Amgen | Raised | Buy | 2026-08-05 | $452.00 | +8.10% |
BMO Capital Amgen | Downgraded | Outperform → Market Perform | 2026-09-08 | $450.00 | +7.60% |
Goldman Sachs Amgen | Raised | Buy | 2026-08-05 | $450.00 | +7.60% |
Oppenheimer Amgen | Raised | Outperform | 2026-08-05 | $450.00 | +7.60% |
UBS Amgen | Raised | Buy | 2026-08-05 | $440.00 | +5.20% |
Wells Fargo Amgen | Raised | Equal-Weight | 2026-09-04 | $435.00 | +4.00% |
HSBC Amgen | Lowered | Buy → Hold | 2026-09-10 | $425.00 | +1.60% |
Citigroup Amgen | Raised | Neutral | 2026-08-07 | $405.00 | −3.20% |
Cantor Fitzgerald Amgen | Reiterated | Neutral | 2026-09-08 | $400.00 | −4.40% |
RBC Capital Amgen | Raised | Outperform | 2026-08-05 | $400.00 | −4.40% |
Guggenheim Amgen | Raised | Neutral | 2026-08-10 | $388.00 | −7.20% |
Canaccord Genuity Amgen | Raised | Hold | 2026-08-05 | $384.00 | −8.20% |
Barclays Amgen | Raised | Equal-Weight | 2026-08-14 | $380.00 | −9.10% |
Morgan Stanley Amgen | Raised | Equal-Weight | 2026-08-19 | $362.00 | −13.50% |
Truist Securities Amgen | Raised | Hold | 2026-08-05 | $362.00 | −13.50% |
Mizuho Amgen | Raised | Neutral | 2026-08-18 | $352.00 | −15.80% |
Bernstein Amgen | Raised | Market Perform | 2026-08-06 | $345.00 | −17.50% |
B of A Securities Amgen | Raised | Underperform | 2026-08-05 | $317.00 | −24.20% |
Baird Amgen | Raised | Underperform | 2026-08-05 | $230.00 | −45.00% |
Institution
Scotiabank
Raised · Sector Outperform · 2026-09-29
$500.00
+19.50%
Argus Research
Raised · Buy · 2026-08-19
$460.00
+10.00%
Piper Sandler
Raised · Overweight · 2026-08-20
$457.00
+9.30%
TD Cowen
Raised · Buy · 2026-08-05
$452.00
+8.10%
BMO Capital
Downgraded · Outperform → Market Perform · 2026-09-08
$450.00
+7.60%
Goldman Sachs
Raised · Buy · 2026-08-05
$450.00
+7.60%
Oppenheimer
Raised · Outperform · 2026-08-05
$450.00
+7.60%
UBS
Raised · Buy · 2026-08-05
$440.00
+5.20%
Wells Fargo
Raised · Equal-Weight · 2026-09-04
$435.00
+4.00%
HSBC
Lowered · Buy → Hold · 2026-09-10
$425.00
+1.60%
Citigroup
Raised · Neutral · 2026-08-07
$405.00
−3.20%
Cantor Fitzgerald
Reiterated · Neutral · 2026-09-08
$400.00
−4.40%
RBC Capital
Raised · Outperform · 2026-08-05
$400.00
−4.40%
Guggenheim
Raised · Neutral · 2026-08-10
$388.00
−7.20%
Canaccord Genuity
Raised · Hold · 2026-08-05
$384.00
−8.20%
Barclays
Raised · Equal-Weight · 2026-08-14
$380.00
−9.10%
Morgan Stanley
Raised · Equal-Weight · 2026-08-19
$362.00
−13.50%
Truist Securities
Raised · Hold · 2026-08-05
$362.00
−13.50%
Mizuho
Raised · Neutral · 2026-08-18
$352.00
−15.80%
Bernstein
Raised · Market Perform · 2026-08-06
$345.00
−17.50%
B of A Securities
Raised · Underperform · 2026-08-05
$317.00
−24.20%
Baird
Raised · Underperform · 2026-08-05
$230.00
−45.00%
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space